Literature DB >> 21278349

Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity.

Peng Zhou1, Chris Cowled, Shawn Todd, Gary Crameri, Elena R Virtue, Glenn A Marsh, Reuben Klein, Zhengli Shi, Lin-Fa Wang, Michelle L Baker.   

Abstract

Bats are known to harbor a number of emerging and re-emerging zoonotic viruses, many of which are highly pathogenic in other mammals but result in no clinical symptoms in bats. The ability of bats to coexist with viruses may be the result of rapid control of viral replication early in the immune response. IFNs provide the first line of defense against viral infection in vertebrates. Type III IFNs (IFN-λs) are a recently identified IFN family that share similar antiviral activities with type I IFNs. To our knowledge, we demonstrate the first functional analysis of type III IFNs from any species of bat, with the investigation of two IFN-λ genes from the pteropid bat, Pteropus alecto. Our results demonstrate that bat type III IFN has similar antiviral activity to type I and III IFNs from other mammals. In addition, the two bat type III IFNs are differentially induced relative to each other and to type I IFNs after treatment or transfection with synthetic dsRNA. Infection with the bat paramyxovirus, Tioman virus, resulted in no upregulation of type I IFN production in bat splenocytes but was capable of inducing a type III IFN response in three of the four bats tested. To our knowledge, this is the first report to describe the simultaneous suppression of type I IFN and induction of type III IFN after virus infection. These results may have important implications for the role of type III IFNs in the ability of bats to coexist with viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278349      PMCID: PMC3057921          DOI: 10.4049/jimmunol.1003115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Pulau virus; a new member of the Nelson Bay orthoreovirus species isolated from fruit bats in Malaysia.

Authors:  L I Pritchard; K B Chua; D Cummins; A Hyatt; G Crameri; B T Eaton; L-F Wang
Journal:  Arch Virol       Date:  2005-10-06       Impact factor: 2.574

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Bats are natural reservoirs of SARS-like coronaviruses.

Authors:  Wendong Li; Zhengli Shi; Meng Yu; Wuze Ren; Craig Smith; Jonathan H Epstein; Hanzhong Wang; Gary Crameri; Zhihong Hu; Huajun Zhang; Jianhong Zhang; Jennifer McEachern; Hume Field; Peter Daszak; Bryan T Eaton; Shuyi Zhang; Lin-Fa Wang
Journal:  Science       Date:  2005-09-29       Impact factor: 47.728

5.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

Authors:  Susanna K P Lau; Patrick C Y Woo; Kenneth S M Li; Yi Huang; Hoi-Wah Tsoi; Beatrice H L Wong; Samson S Y Wong; Suet-Yi Leung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

6.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

7.  Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.

Authors:  Nathan W Bartlett; Karen Buttigieg; Sergei V Kotenko; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-06       Impact factor: 3.891

8.  Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.

Authors:  Ahmed Lasfar; Anita Lewis-Antes; Sergey V Smirnov; Shubha Anantha; Walid Abushahba; Bin Tian; Kenneth Reuhl; Harold Dickensheets; Faruk Sheikh; Raymond P Donnelly; Elizabeth Raveche; Sergei V Kotenko
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

9.  Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats.

Authors:  M M Williamson; P T Hooper; P W Selleck; L J Gleeson; P W Daniels; H A Westbury; P K Murray
Journal:  Aust Vet J       Date:  1998-12       Impact factor: 1.281

Review 10.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

View more
  56 in total

1.  Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Authors:  Eva Perez-Martin; Marcelo Weiss; Fayna Diaz-San Segundo; Juan M Pacheco; Jonathan Arzt; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Functional characterization of canine interferon-lambda.

Authors:  Wenhui Fan; Lei Xu; Liqian Ren; Hongren Qu; Jing Li; Jingjing Liang; Wenjun Liu; Limin Yang; Tingrong Luo
Journal:  J Interferon Cytokine Res       Date:  2014-06-20       Impact factor: 2.607

3.  Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats.

Authors:  Peng Zhou; Mary Tachedjian; James W Wynne; Victoria Boyd; Jie Cui; Ina Smith; Christopher Cowled; Justin H J Ng; Lawrence Mok; Wojtek P Michalski; Ian H Mendenhall; Gilda Tachedjian; Lin-Fa Wang; Michelle L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

4.  Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.

Authors:  Nicole B Glennon; Omar Jabado; Michael K Lo; Megan L Shaw
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  Deep RNA sequencing reveals complex transcriptional landscape of a bat adenovirus.

Authors:  Lijun Wu; Peng Zhou; Xingyi Ge; Lin-Fa Wang; Michelle L Baker; Zhengli Shi
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Interferon-λ1 suppresses invasion and enhances autophagy in human osteosarcoma cell.

Authors:  Dongmei Gao; Jun Zhao; Xiuyi Li; Yuanyuan Xia; Yu Cai; Jiwen Pan; Hong Zhou; Yong Fang; Shouzhu Zhang; He Wen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.

Authors:  Teresa Aydillo; Juan Ayllon; Amzie Pavlisin; Carles Martinez-Romero; Shashank Tripathi; Ignacio Mena; Andrés Moreira-Soto; Amanda Vicente-Santos; Eugenia Corrales-Aguilar; Martin Schwemmle; Adolfo García-Sastre
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

8.  Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.

Authors:  Zhiwei Yin; Jihong Dai; Jing Deng; Faruk Sheikh; Mahwish Natalia; Tiffany Shih; Anita Lewis-Antes; Sheela B Amrute; Ursula Garrigues; Sean Doyle; Raymond P Donnelly; Sergei V Kotenko; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2012-08-13       Impact factor: 5.422

9.  Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.

Authors:  Ivan V Kuzmin; Toni M Schwarz; Philipp A Ilinykh; Ingo Jordan; Thomas G Ksiazek; Ravi Sachidanandam; Christopher F Basler; Alexander Bukreyev
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

10.  Anti-lyssaviral activity of interferons κ and ω from the serotine bat, Eptesicus serotinus.

Authors:  Xiaocui He; Tomaš Korytař; Juliane Schatz; Conrad M Freuling; Thomas Müller; Bernd Köllner
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.